Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity

Abstract

Atherosclerosis has long been considered as a lipid storage disease. Recent data suggest that autoimmune mechanisms seem to be involved in the pathophysiology of atherosclerosis. The presence of activated endothelial vascular cells, neutrophils, macrophages, T and to a lesser extent B cells in atherosclerotic plaques, together with the proinflammatory cytokine burden suggest mobilization of both innate and adaptive immune pathways in atherosclerosis pathobiology. The development of antibodies to oxidized low-density lipoprotein (ox-LDL), the experimental induction of atherosclerosis either via the transfer of T cells or immunization with autoantigens such as β2 glycoprotein Ι (β2-GPI) and heat shock proteins (HSP) further support the autoimmune nature of atherosclerosis. However, classical immunosuppressive and immune-modulatory drugs, successfully used in the therapy of autoimmune rheumatic diseases have shown limited benefits so far in the treatment of atherosclerosis. K E Y W O R D Satherosclerosis, autoimmune disease, autoimmune response, oxidized form of low-density lipoprotein

Resveratrol in Cancer Patients: From Bench to Bedside

“…Preclinical and updated clinical evidence on the effects of resveratrol in cardiology is presented, with interesting implications in the cardio-oncological field, considering that some cardiac targets share common tumor targets, tightening on its possible use as a cardioprotective agent in cardio-oncology. Resveratrol has demonstrated to significantly reduce the oxidation of low-density lipoprotein (Ox-LDL), which is the key initiation point of atherosclerosis as well as a source of survival and resistance in breast, colon and prostate cancer cells through the involvement of β-catenin, cMyc, NF-κB, STAT1, STAT3 and other oncogenes [96][97][98]. Moreover, resveratrol has shown to reduce the risk of thrombosis through inhibition of platelet aggregation in preclinical models [99], Considering that venous thromboembolism is a major health problem among cancer patients [100], associated with high rates of mortality and morbidity, the possible use of resveratrol in this category of patients could be interesting.…”

Hsa_circ_0000345 regulates the cellular development of ASMCs in response to oxygenized low‐density lipoprotein

“…During the progress of the primary lesions in atherosclerosis, monocytes migrate, proliferate and differentiate into macrophages in the arterial intima gradually, and macrophages swallow ox‐LDL, forming lipid‐laden macrophages (also called foam cells). Subsequently, foam cells and smooth muscle cells proliferate and eventually progress to advanced plaques 25,26 . Thus, exploring cell development mechanisms during ox‐LDL stress, for example, circRNA regulation, may help to uncover the distinctive and overlapping mechanisms of atherosclerosis, leading to effective targets.…”

Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19

“…Circulating low-density lipoproteins (LDL) are deposited in the intima at lesion-prone sites and undergo oxidative modification to generate oxidised LDL (OxLDL), which is a potent inflammatory mediator that triggers endothelial dysfunction (6,7). Endothelial cells respond to OxLDL by expressing adhesion molecules such as ICAM-1 and chemokines including monocyte chemotactic protein-1 (MCP-1/CCL2) for recruitment of leukocytes (7,8).…”